Newsfeed : Acyclovir for Genital Herpes Does Not Reduce HIV Risk

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Newsfeed » August 2008

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

August 12, 2008

Acyclovir for Genital Herpes Does Not Reduce HIV Risk

Researchers at the XVII International AIDS Conference in Mexico City affirmed that long-term treatment of genital herpes with the drug acyclovir does not reduce HIV transmission risk, Reuters reports.

In a randomized trial, researchers evaluated the effects of acyclovir in 1,814 men who have sex with men (MSM) from the United States and Peru, and in 1,358 women from Zimbabwe, Zambia and South Africa. All were HIV negative and living with herpes simplex virus type 2 (HSV-2), which causes genital herpes.

Participants took acyclovir or placebo pills twice each day and were followed monthly for up to 18 months. After that period, researchers observed that incidences of HIV infection were the same in both groups.

According to the article, researchers suggest that genital herpes may be a risk marker—not a risk factor—for HIV, and they suggested that interventions against HSV-2 should be better implemented in these regions.

Search: acyclovir, International AIDS Conference , genital herpes


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)

 
[Go to top]

Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    charliehunter
    San Francisco
    California


    Loveladyd
    Washington
    DC


    Deelight4u
    BROOKLYN
    New York


    Fergie911
    Chicago
    Illinois
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Do you work with your doc to design your own treatment regimen?
Yes
No

Survey
PrEP Course

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.